sPD-L1 have been described in several malignancies including renal cell cancer, pancreatic cancer, rectal cancer, B-cell lymphoma, multiple myeloma and melanoma [35,36,37,38,39]. The gene discussed is SPDL1; the disease is plasma cell myeloma.